Home > Insider Trading > Filing (0001555280-20-000142)

Filing Details

Accession Number:: 0001555280-20-000142
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-06 17:19:58
Reporting Period:: 2020-03-05

Accepted Time:: 2020-03-06 17:19:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1555280	Zoetis Inc.	ZTS	Pharmaceutical Preparations (2834)	460696167

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1606256	Glenn David	C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-03-05	11,144	$50.22	36,885	No	4	M	Direct
Common Stock	Acquisiton	2020-03-05	32,634	$55.02	69,519	No	4	M	Direct
Common Stock	Disposition	2020-03-05	35,838	$140.81	33,681	No	4	S	Direct
Common Stock	Disposition	2020-03-05	7,940	$141.24	25,741	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2020-03-05	11,144	$0.00	11,144	$0.00
Common Stock	Stock Option	Disposition	2020-03-05	32,634	$0.00	32,634	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
110,103			No	4	M	Direct
77,469			No	4	M	Direct

Footnotes

The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.11 to $141.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.12 to $141.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
11,144 options granted December 6, 2016 at an exercise price of $50.22 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; and 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option.
32,634 options granted February 14, 2017 at an exercise price of $55.02 per option.
7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; and 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option.